Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Prevnar 13"'
Autor:
Allison R. Thompson, Nicola P. Klein, H. Jackson Downey, Scott Patterson, Vani Sundaraiyer, Wendy Watson, Keri Clarke, Kathrin U. Jansen, Shite Sebastian, William C. Gruber, Daniel A. Scott, Beate Schmöele-Thoma
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 2, Pp 444-451 (2019)
Immune responses to 13-valent pneumococcal conjugate vaccine (PCV13) and quadrivalent inactivated influenza vaccine (QIV) in older adults may vary with coadministration and previous pneumococcal polysaccharide vaccination. This study assessed safety
Externí odkaz:
https://doaj.org/article/538518ef02b44b0b88cb3f4861a8e7c6
Autor:
Raul E. Isturiz, Cassandra Hall-Murray, John M. McLaughlin, Vincenza Snow, Beate Schmoele-Thoma, Chris Webber, Allison Thompson, Daniel A Scott
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 1, Pp 45-55 (2018)
Introduction; Adults, particularly those with underlying chronic conditions, eg, cardiovascular, liver, and pulmonary diseases and diabetes mellitus, have a persistent pneumococcal disease burden. Thirteen-valent pneumococcal conjugate vaccine (PCV13
Externí odkaz:
https://doaj.org/article/6f6cee40e7e942f1b353c1ef8c70e624
Autor:
Chitrananda Abeygunawardana, Jon E. Stek, Lucy Roalfe, Andrea Likos Krick, Tina M. Sterling, John Ervin, David Krupa, Meihua Wang, Charles P. Andrews, Temitope Folaranmi, Ulrike K. Buchwald, Jonathan Hartzel, Melvin A Kohn, Luwy Musey, Gretchen M. Tamms, Patrick Ajiboye, James T. Peterson, Jason C. Martin
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
In most countries worldwide, pneumococcal conjugate vaccines have been included in the infant immunization program, resulting in a significant reduction in the burden of pneumococcal disease in children and adults. Shifting serotype distribution due
Autor:
Mariel O. Watkins, Sonya Malekzadeh, Jaeil Ahn, Stephanie Y. Johng, Sarah M. Dermody, Earl H. Harley
Publikováno v:
The Annals of otology, rhinology, and laryngology. 131(8)
Introduction/Objective: Historically, myringotomy, and the insertion of tympanostomy tubes has served as one of the initial surgical training experiences for residents. Resident experience with this procedure since the introduction of pneumococcal co
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aaron J. Cabago, Joseph Karl N. Hufalar, Jennifer C. Dela Cruz, John Raphael R. Moredo, Gina L. Hanopol, Jhester B. Bregonia, Mark Christian E. Manuel, Paulo Rafael V. Meris
Publikováno v:
2020 11th IEEE Control and System Graduate Research Colloquium (ICSGRC).
The objective of the study was to develop a portable thermoelectric cooler with Arduino-based temperature controller for Prevnar 13 vaccine using Polyurethane foam, Polyethylene foam and fiberglass for the container. Details on how the designed proto
Autor:
Keri Clarke, Kathrin U. Jansen, Beate Schmoele-Thoma, Daniel A. Scott, Vani Sundaraiyer, Scott Patterson, Shite Sebastian, Nicola P. Klein, H. Jackson Downey, Allison Thompson, Wendy Watson, William C. Gruber
Publikováno v:
Human Vaccines & Immunotherapeutics
Immune responses to 13-valent pneumococcal conjugate vaccine (PCV13) and quadrivalent inactivated influenza vaccine (QIV) in older adults may vary with coadministration and previous pneumococcal polysaccharide vaccination. This study assessed safety
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Inci Yildirim, Stephanie Thomas, Monica M. Farley, Folashade Omole, Marianne McPherson Yee, Peter A. Lane, Kristina Lai, Amy Tunali, Thomas V. Adamkiewicz
Publikováno v:
Blood. 138:763-763
Before prophylactic antibiotic use, approximately 1/10 children Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare.
Autor:
Arumugham, Vinu
An autism vaccine injury claim was denied by the US Vaccine Injury Compensation Program. In this case, the proper scientific cause was not described. Due to this science misstep and others, the compensation was denied. The details of the mistakes are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c85af59962513a1877a8563d676f64